Glucagon-like peptide-1 receptor agonists such as Ozempic have the potential to alter the way ASCs go about procedures.
Why ASC leaders should pay attention to weight loss drugs
Glucagon-like peptide-1 receptor agonists such as Ozempic have the potential to alter the way ASCs go about procedures.